Literature DB >> 8002536

Effects of cocaine, benzoylecgonine, and cocaine metabolites in cannulated pressurized fetal sheep cerebral arteries.

M D Schreiber1, J A Madden, R F Covert, L J Torgerson.   

Abstract

Prenatal cocaine exposure has been reported to cause neurovascular complications in the developing fetus. To determine the effect of cocaine on the fetal neurovasculature, we studied the in vitro response of fetal sheep cerebral arteries to cocaine and cocaine metabolites. The change in diameter of cannulated pressurized cerebral artery segments from fetal sheep was measured using a video microscaler system. Cumulative dose-response curves (10(-12)-10(-4) M) were generated for cocaine and the major cocaine metabolites in fetal sheep cerebral artery segments. Benzoylecgonine (> 10(-10) M) also caused concentration-dependent constriction, and cerebral artery segments were significantly more sensitive to benzoylecgonine than to cocaine and the other cocaine metabolites. Benzoylecgonine-induced vasoconstriction appeared to be mediated through alpha-adrenergic stimulation, predominantly through stimulation of alpha 1-adrenergic receptor subtypes. We conclude that cocaine and benzoylecgonine cause significant fetal cerebral artery vasoconstriction in vitro. Cocaine and benzoylecgonine-induced cerebral vasoconstriction may contribute to the perinatal neurovascular complications associated with prenatal cocaine exposure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8002536     DOI: 10.1152/jappl.1994.77.2.834

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  2 in total

1.  Pharmacokinetics of cocaine and metabolites following intragastric administration to ten-day-old rat pups.

Authors:  N N Nyamweya; B J Gurley; P Breen; K E Light
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

2.  Metabolic Enzymes of Cocaine Metabolite Benzoylecgonine.

Authors:  Xiabin Chen; Xirong Zheng; Max Zhan; Ziyuan Zhou; Chang-Guo Zhan; Fang Zheng
Journal:  ACS Chem Biol       Date:  2016-06-09       Impact factor: 5.100

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.